RECURSION LONDON LTD
Company number 12648333 · Monitor this company
The most recent accounts indicate this company is dormant and not trading.
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£1
Balance sheet as at 2020-11-30
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-06-05
- Registered office
- 3rd Floor 1 Ashley Road, Altrincham, Cheshire, United Kingdom, WA14 2DT
- Postcode
- WA14 2DT
- Capital
- 1 GBP
- Accounts category
- Small
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-06-04
- Next due by
- 2027-06-18
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current · 8 resigned
Group structure
Controlled by Recursion Pharmaceuticals, Inc. (05426554) — since 2023-05-25
From persons-with-significant-control filings on the public register.
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Global Business Mobility: Senior or Specialist Worker (Worker (A rating)), Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Data protection registration
Registered with the ICO as a data protection fee payer — ZB884269 (Tier 1), registered since 2025.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Previous company names
| Name | Date changed |
|---|---|
| CYCLICA LTD | 2024-03-26 |
Competitors Warrington
This company ranks 24 among research and experimental development on biotechnology in Warrington.
The class of 2020
41%
of the 595 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.
A fact about the year, not a forecast for this company.